Estatísticas para Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months

Total de visitas

views
Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months 0

Total visitas por mês

views
junho 2024 0
julho 2024 0
agosto 2024 0
setembro 2024 0
outubro 2024 0
novembro 2024 0
dezembro 2024 0